Convergence-the increasing overlap of media, computing, and communications-is providing broad connectivity for a wealth of digitized health care information that is being developed by health care providers, technology companies, and consumers themselves. This article examines the impact of convergence on the health care industry and identifies the strategic questions it raises for pharmaceutical and device manufacturers.

Drug firms and PBMs each bring valuable assets to the disease management party—and different, perhaps conflicting goals. But can they live without each other?